MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Botulinum neurotoxin type A versus placebo for hemifacial spasm in adults – 2016 Cochrane movement disorders group systematic review update

    M. Castelão, F.B. Rodrigues, R.E. Marques, G.S. Duarte, J.J. Ferreira, P. Moore, J. Costa (Lisboa, Portugal)

    Objective: To update a Cochrane review comparing botulinum neurotoxin type A (BtA) to placebo in adults with hemifacial spasm (HFS). Background: This is an update…
  • 2016 International Congress

    Novel mutations identified in dopamine transporter deficiency syndrome

    J. Ng, J. Zhen, K. Erreger, N.C. Oien, S. Mohammed, J.P. Linn, J. Muntadas, I. Denzler, A. Garcia Cazorla, R. Artuch, S. Pope, S.J.R. Heales, A. Galli, M.E.A. Reith, M.A. Kurian (London, United Kingdom)

    Objective: We aim to describe clinical phenotype, genotype and functional studies in a new cohort patients identified with Dopamine Transporter deficiency syndrome (DTDS). Background: Dopamine…
  • 2016 International Congress

    Assessment of oral hygiene status before and after the use of powered tooth brush in patients with Parkinson’s diseases

    F. Pullishery, F.M. Kuyyadi (Malappuram, India)

    Objective: The objective of this study was to assess the oral hygiene status, gingival status and also the Oral health related quality of life (OHRQoL)…
  • 2016 International Congress

    Has iCare PD started in Singapore?

    S.H.X. Liew, C. Cyq, N. Jcf, K. Sym, R.C.L. Ong (Singapore, Singapore)

    Objective: To evaluate if interdisciplinary care (iCare) is present in the management of Parkinson's disease (PD) among PD Allied Health Professionals (AHP) at a centre…
  • 2016 International Congress

    Long-latency somatosensory evoked potentials of the subthalamic nucleus

    C. Trenado, S. Elben, L. Friggemann, S. Gruhn, S. Groiss, J. Vesper, A. Schnitzler, L. Wojtecki (Düsseldorf, Germany)

    Objective: This study aims to clarify the role of the STN, previously suggested as an integrative component in the control of the basal ganglia-thalamocortical circuit,…
  • 2016 International Congress

    Stiff person syndrome

    P. Dosekova, G. Krastev, J. Haring, R. Lackovic (Trnava, Slovakia (Slovak Republic))

    Objective: Two case reports of Stiff person syndrome (SPS) and SPS variant- Stiff limb syndrome. Background: Stiff person syndrome is a rare autoimmune disorder of…
  • 2016 International Congress

    Safety of nelotanserin in a randomized placebo-controlled phase 2 study

    W. Wen, L. Friedhoff, K. Kishnani, S. Ramaswamy, S. Piscitelli, M. Sanchez, W. Shanahan (New York, NY, USA)

    Objective: To explore the safety of nelotanserin in a phase 2 study in patients with nelotanserin. Background: Nelotanserin is a highly selective and poent inverse…
  • 2016 International Congress

    AMP kinase regulates ligand-gated K-ATP channels in substantia nigra dopamine neurons

    S.W. Johnson, Y. Wu, A.C. Munhall, K.Z. Shen (Portland, OR, USA)

    Objective: To characterize the effect of AMP-activated protein kinase (AMPK) on ATP-sensitive K+ (K-ATP) channels on substantia nigra compacta (SNC) dopamine neurons in slices of…
  • 2016 International Congress

    Clinical characterization of pramipexole induced edema in Parkinson’s disease (PD). Is it always the best option discontinue the treatment?

    E. Urrea-Mendoza, F.J. Revilla (Greenville, SC, USA)

    Objective: Report a patient with PD treated with irregular doses of pramipexole and extensive chronic edema in lower extremities after 8 years of treatment, taking…
  • 2016 International Congress

    Fighting Freezing of gait in Parkinson’s disease: Effect of a phase-dependent tactile biofeedback

    M. Mancini, K. Smulders, G. Harker, A.C. Fortaleza, J.G. Nutt, F.B. Horak (Portland, OR, USA)

    Objective: To investigate the effect of tactile biofeedback during every stance phase on freezing of gait (FoG) in Parkinson's disease (PD). Background: Accumulating evidence suggests…
  • « Previous Page
  • 1
  • …
  • 184
  • 185
  • 186
  • 187
  • 188
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley